Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy
Not Applicable
Withdrawn
- Conditions
- Head and Neck Cancer
- Registration Number
- NCT00375700
- Lead Sponsor
- AHS Cancer Control Alberta
- Brief Summary
In this study, an oral nutrition supplement has been developed that take into consideration: the nutritional requirements, treatment side-effects and taste preferences of head and neck cancer patients; the acceptance of a supplement when experiencing radiation therapy side-effects; and the taste preferences of head and neck cancer patients which may affect the supplement intake. We hope to increase dietary intake during the last 2 weeks of radiation therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- 18 years or older
- diagnosed with head and neck cancer including the lip, oral cavity, salivary glands, paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx and thyroid.
- all histologic types of cancer
- all tumour stages according to American Joint Committee for Cancer (AJCC) Staging
- all forms of RT including standard or investigational for head and neck cancers
- alert and mentally competent
- English speaking
Exclusion Criteria
- an allergy or intolerance to any of the substances used in the nutrition supplement
- Type I or II diabetes mellitus
- renal insufficiency
- unable to swallow
- additional criteria of all forms of chemotherapy standard or investigational or combination of radiation/chemotherapy standard or investigational for head and neck cancers
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method total energy and protein intake Study completion
- Secondary Outcome Measures
Name Time Method